- Abstract Number: 931
Ultra-Low Doses of Rituximab for Retreatment of RA: A Randomized Controlled Non-Inferiority Trial
- Abstract Number: 2672
Ultrasonography in the Diagnosis of Giant Cell Arteritis
- Abstract Number: 1448
Ultrasonography of Major Salivary Glands in Primary Sjögren’s Syndrome: Identification of Distinct Evolving Patterns in the Long-Term Follow-up
- Abstract Number: 297
Ultrasound and Magnetic Resonance Imaging Evaluation of the Fingers’ Joints of Psoriatic Arthritis Patients – Interim Analysis
- Abstract Number: 898
Ultrasound Demonstrates Rapid Reduction of Crystal Depositions During a Treat-to-target Approach in Gout Patients: Two-year Results from a Longitudinal, Observational Study (NOR-GOUT)
- Abstract Number: 2607
Ultrasound Detection of Calcinosis and Correlation with Ulnar Artery Occlusion in Patients with Systemic Sclerosis
- Abstract Number: 287
Ultrasound Evaluation of the Achilles Enthesis in Inflammatory and Non-inflammatory Processes: A Systematic Review
- Abstract Number: 711
Ultrasound Evaluation of the Hands in Patients with Systemic Sclerosis: Osteophytosis Is a Major Contributor to Tender Joints
- Abstract Number: 1360
Ultrasound Guided Synovial Biopsies Safely Aid in the Assessment of Inflammatory Arthritis
- Abstract Number: 282
Ultrasound Is More Sensitive Compared to Conventional Radiography to Detect Joint Erosions in ACPA-positive Patients with Musculoskeletal Pain
- Abstract Number: 721
Ultrasound Measurement of the Nail Bed Matrix Thickness as a Useful Marker for Scleroderma-Related Interstitial Lung Disease
- Abstract Number: 2644
Ultrasound to Monitor Treatment Response in Large Vessel Giant Cell Arteritis
- Abstract Number: 280
Ultrasound versus Conventional Treat-To-Target Strategies in Early Rheumatoid Arthritis: Magnetic Resonance Imaging Outcome Data from a 2-year Randomized Controlled Strategy Trial
- Abstract Number: 78
Ultraviolet Light Induces Increased T Cell Activation in Lupus-Prone Mice via Type I Interferon-Dependent Inhibition of T Regulatory Cells
- Abstract Number: 796
Under Detection of Interstitial Lung Disease in Juvenile Systemic Sclerosis (jSSc) Utilizing Pulmonary Function Tests: Results from the Juvenile Scleroderma Inception Cohort
- Abstract Number: 1144
Understanding Clinical Trials Participation Among Individuals of African Descent with Lupus Through the Lens of Critical Race Theory: A Qualitative Analysis
- Abstract Number: 2083
Understanding Knee Function and Symptom Management in Individuals with Risk Factors for Knee Osteoarthritis
- Abstract Number: 2037
Understanding Langerhans Cell ADAM17 Levels in Systemic Lupus Erythematosus: Potential Contributor to Photosensitivity
- Abstract Number: 568
Understanding mNY Radiograph Score Discordance in Axial Spondyloarthritis Clinical Trials Using Imaging Criteria for Subject Eligibility
- Abstract Number: 367
Understanding the Mystery of Sarcoidosis: An Academic Rheumatology Center Experience
- Abstract Number: 2251
Understanding Vulnerabilities in Diagnosis and Care of Childhood and Adult-Onset Lupus: A Qualitative Study
- Abstract Number: 435
Understanding Which Patient-Reported Outcomes Are Important to Rheumatology Patients: Findings from ArthritisPower
- Abstract Number: 18
Undifferentiated Connective Tissue Disease at Risk for SSc: Potential Role of Circulating CXCL-10, CXCL-11 and IL-33 in Predicting Disease Evolution
- Abstract Number: 79
Unique Primed Status of Microglia Under the Systemic Autoimmune Condition of Lupus-Prone Mice
- Abstract Number: 1332
United States Rheumatology Practice-Based Real-World Evidence of Infusion Reactions in Rheumatoid Arthritis Patients Treated with Intravenous Golimumab or Infliximab: Impact of Prior Biologic Exposure and Methotrexate Utilization
- Abstract Number: 2479
Unmet Treatment Needs in Patients with Psoriatic Arthritis
- Abstract Number: 513
Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 Weeks
- Abstract Number: 518
Upadacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Biological DMARDs: Results at 60 Weeks
- Abstract Number: 551
Upadacitinib Treatment and the Routine Assessment of Patient Index Data 3 (RAPID3) Among Patients with Rheumatoid Arthritis
- Abstract Number: 1219
Uric Acid Level as a Predictor of Long Term Mortality in Advanced Age Population
- Abstract Number: 1037
Urinary C3d Is a Good Marker for Monitoring Treatment Response After 3 Months of Induction Treatment in Patients with Biopsy Proven Lupus Nephritis
- Abstract Number: 2570
Urinary Cellular Profile as a Biomarker for Proliferative Lupus Nephritis
- Abstract Number: 2629
Urinary Inflammatory Cell Analysis Reflects the Renal Histopathology in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- Abstract Number: 690
Urinary MRP8/14, an Endogenous Toll-Like Receptor 4 Ligand, Reflects Renal Disease Activity in Lupus Nephritis: A Cross-Sectional and Longitudinal Assessment
- Abstract Number: 1918
Urine CD163 Significantly Discriminates Active Lupus Nephritis and Strongly Correlates with Proliferative Glomerulonephritis
- Abstract Number: 2637
Urine Complement Ba Levels During Flares of Renal Disease in Patients with ANCA-Associated Vasculitis
- Abstract Number: 1118
US Community Rheumatologists’ Knowledge and Perceptions of Biosimilar Expanded Indication Approval by Extrapolation
- Abstract Number: 549
US Rheumatologists’ Beliefs and Knowledge About Biosimilars – an Ongoing Survey
- Abstract Number: 2059
Usage of Predicting Out-of-Office Blood Pressure Calculator in Hispanic Patients with Rheumatic Diseases
- Abstract Number: 2394
Use and Influence of Biologic/Janus Kinase Monotherapy Among Recently Switched Rheumatoid Arthritis Patients: Results from an Annual National Patient Chart Audit
- Abstract Number: 1861
Use of a Novel Electronic Auto-notification Process to Manage Transitions of Care in Rheumatic Patients on DMARD Therapy
- Abstract Number: 161
Use of a Systematic Consensus Process to Inform Development of the Veterans Health Affairs Simulation Learning, Education and Research Network (SimLEARN) Musculoskeletal Clinician Course
- Abstract Number: 2462
Use of Complementary and Alternative Medicine (CAM) in a Psoriatic Arthritis Cohort
- Abstract Number: 2412
Use of Minimal Important Difference (MID) in Randomized Clinical Trials of Pain in Osteoarthritis
- Abstract Number: 1672
Use of Rituximab for the Treatment of ANCA-Associated Vasculitis in Canada, 2010-2018
- Abstract Number: 370
Use of Serum Lung Injury Biomarkers for Predicting the Severity of Interstitial Lung Disease in Patients with Connective Tissue Disease Associated Interstitial Lung Disease and Interstitial Pneumonia with Autoimmune Features
- Abstract Number: 2832
Using a Learning Collaborative to Develop an RA Disease Activity Communication Tool to Promote Shared Decision-Making in Treat to Target
- Abstract Number: 1860
Using Electronic Visits (E-Visits) to Achieve Goal Serum Urate Levels in Patients with Gout in a Rheumatology Practice: A Pilot Study
- Abstract Number: 2410
Using External Data to Estimate Omitted Variables in Observational Data: A Plasmode Simulation Study Investigating the Relationship Between Osteoarthritis and Cardiovascular Diseases to Compare Alternative Approaches in Imputing the Body Mass Index Variable
- Abstract Number: 1906
Using Multi-modal Ultrasound to Assess Disease Activity Within the Salivary Glands of Patients with Primary Sjögren’s Syndrome Treated with Ianalumab (VAY736)
- Abstract Number: 1246
Using PROMIS Data to Assess Activity of Inflammatory Eye Disease
- Abstract Number: 1539
Ustekinumab and TNF Inhibitors Similarly Improve Patient-perceived Impact of Psoriatic Arthritis but Differentially Affect the Scale Subdomains: Results from a European Observational Cohort Study
- Abstract Number: 1837
Ustekinumab for the Treatment of Giant Cell Arteritis
- Abstract Number: 662
Utility of a Mobile Phone Based Application to Collect Patient-Reported Outcome Information from People Living with Systemic Lupus Erythematosus
- Abstract Number: 407
Utility of Anti-SSA/SSB Assay and Anti-Ro 52 Antibody Assay in Routine Clinical Practice for Risk Assessment of Patients with Idiopathic Inflammatory Myositis
- Abstract Number: 1165
Utility of Coronary Calcium Scoring (CCS) in the Spectrum of Connective Tissue Disorders (CTDs) for the Evaluation of Subclinical Coronary Atherosclerosis – a Systematic Review
- Abstract Number: 212
Utility of Mood Disorders Questionnaire in Fibromyalgia: Data from the Cleveland Clinic Fibromyalgia Registry
- Abstract Number: 303
Utility of Power Doppler Ultrasound–Detected Synovitis for the Prediction of Flare in Psoriatic Arthritis Patients in Clinical Remission
- Abstract Number: 1802
Utility of Repeat Latent Tuberculosis Testing in Patients Taking Biologics
- Abstract Number: 665
Utility of Repeat Renal Biopsies in Patients with Lupus Nephritis in Western Australia
- Abstract Number: 1361
Utility of Rheumatoid Arthritis Impact of Disease (RAID) in Routine Care; Identification of Patients Achieving DAS28 Remission or Low Disease Activity, and Burden of Unmet Patient Reported Outcomes
- Abstract Number: 1210
Utilization of a Multispecialty Team for the Diagnosis of Giant Cell Arteritis Reduces Patient Morbidity
- Abstract Number: 2711
Utilization of Biologic Treatments in Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis
- Abstract Number: 1762
UV Light Induces Acute Type I Interferon Production in the Skin and Blood Which Is cGAS Dependent
- Abstract Number: 81
UV Light Stimulates a Systemic Neutrophil Response Associated with Transient Kidney Injury
- Abstract Number: 2481
Uveitis in 320 Patients with Psoriatic Arthritis. Epidemiology, Clinical Features and Biological Treatment: Study from a Single University Center
2019 ACR/ARP Annual Meeting
November 8-13, 2019. Atlanta, GA.